MASLD: A practical diagnostic and treatment pathway

Chew NWS Mehta A Goh R , et al. (2026) The global cardiovascular–liver–metabolic syndemic: Epidemiology, trends and challenges. Nature Reviews Cardiology 23(4): 219–238. DOI: 10.1038/s41569-025-01220-4.

European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) (2024) EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Journal of Hepatology 81(3): 492–542. DOI: 10.1016/j.jhep.2024.04.031.

Hagström H Nasr P Ekstedt M , et al. (2017) Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. Journal of Hepatology 67(6): 1265–1273. DOI: 10.1016/j.jhep.2017.07.027.

Harrison SA Bedossa P Guy CD , et al. (2024) A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. New England Journal of Medicine, 390(6): 497–509. DOI: 10.1056/NEJMoa2309000

Huang DQ Rinella ME Loomba R , et al. (2025) Metabolic dysfunction-associated steatotic liver disease in adults. Nature Reviews Disease Primers 11(1): 14. DOI: 10.1038/s41572-025-00599-1.

McPherson S Armstrong MJ Cobbold JF , et al. (2022) Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): Consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group. The Lancet Gastroenterology & Hepatology 7(8): 755–769. DOI: 10.1016/S2468-1253(22)00061-9.

Ng CH Lim WH Hui Lim GE , et al. (2023) Mortality outcomes by fibrosis stage in NAFLD: a systematic review and meta-analysis. Clinical Gastroenterology and Hepatology 21(4): 931–939.e5. DOI: 10.1016/j.cgh.2022.04.014.

NICE (2016) Non-alcoholic fatty liver disease (NAFLD): Assessment and management. NICE Guideline NG49. Available at: www.nice.org.uk/guidance/ng49 (accessed 12 November 2025).

Taylor RS Taylor RJ Bayliss S , et al. (2020) Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Gastroenterology 158(6): 1611–1625.e12. DOI: 10.1053/j.gastro.2020.01.043.